comparemela.com

Latest Breaking News On - Peter lebowitz - Page 1 : comparemela.com

Rx Rundown: Bristol Myers Squibb, J&J, Pfizer and more

Check out a roundup of this week’s medical marketing news, executives on the move and industry chatter.

New jerseyUnited statesNorth carolinaEli lillyJeffrey liebmannScott wassermanGiovanni caforioDominic nick marascoRyan linderChristopher rileyMonica telladoChris paquetteCris mortonRainer blairLeo gradyStevenj pully

Longtime BioMarin CEO hands off baton—Chutes & Ladders

Longtime BioMarin CEO hands off baton—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Ocuphire pharmaAmit mehtaDerrell porterKirsty sempleErin lavelleCellevolve bioSarah coleTodd dickinsonAdrian rayPaul frohnaMichelle shuffettJennifer towneMarguerite hutchinsonChristian howellLori kunkelDaiichi sankyo plexxikon

Amivantamab With Lazertinib Can Reduce Risk of Disease Progression By 30% in Patients With NSCLC

Compared to osimertinib alone, first-line treatment with amivantamab plus lazertinib was also shown to improve progression-free survival and have an increased duration of response.

Soult ukpyolsiSouth koreaRepublic of koreaByoung chul choPeter lebowitzYonsei universityCollege of medicineJanssen research developmentYonsei cancer centerEuropean society of medical oncologyJanssen pharmaceuticalMedical oncologyJanssen research

J&J Pushes Back on Market Reaction to Patient Trial of Its Lung Cancer Drug

J&J Pushes Back on Market Reaction to Patient Trial of Its Lung Cancer Drug
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesDavid risingerYaron werberBloomberg johnsonPeter lebowitzEuropean society for medical oncologyAstrazeneca plcLeerink partnersEuropean societyMedical oncology

Johnson & Johnson : Janssen Aims to Define New Standards of Care in the Treatment of Solid Tumor Cancers with Transformative Data Planned for Presentation at ESMO -October 16, 2023 at 08:33 am EDT

News Release Media Contacts: Brian Kenney +1 215-620-0111 Suzanne Frost +1.

Janssen cilag gmbPeter lebowitzMartin vogelJanssen research developmentGlobal therapeutic area headJanssen researchArea lead oncologyPresidential symposium

vimarsana © 2020. All Rights Reserved.